trending Market Intelligence /marketintelligence/en/news-insights/trending/z1rFEjtMoMQ76MGsH33nlw2 content esgSubNav
In This List

ImmunoPrecise to acquire U-Protein for €6.8M

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


ImmunoPrecise to acquire U-Protein for €6.8M

ImmunoPrecise Antibodies Ltd. acquired all of U-Protein Express BV's issued and outstanding shares for €6.8 million.

ImmunoPrecise will pay €2.7 million in cash, issue €2 million of its shares and settle the remaining €2 million over a three-year period, either in cash or stock.

Martin Hessing, one of the principal shareholders of U-Protein, will join the ImmunoPrecise board.

ImmunoPrecise recently upsized a private placement to use the proceeds for the acquisition of U-Protein.